Login to Your Account



Trans-Pacific partners TNI, Qianjiang advance MENK immunotherapy

By Cornelia Zou
Staff Writer

Wednesday, August 20, 2014

HONG KONG – A Chinese pharmaceutical company and its American partner have announced their plan to accelerate collaboration on the development of cancer drugs, with an eye on launching clinical trials in China soon.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription